Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC43274 Citromycetin

    柠檬菌素

    A fungal metabolite
  3. GC43259 Cholesteryl Homo-γ-Linolenate

    20:3 (8Z,11Z,14Z) CE, 20:3 n-6 CE, 20:3 (8Z,11Z,14Z) Cholesterol Ester

    A cholesterol ester
  4. GC43252 Cholesterol β-D-Glucoside

    β-ChlGlc, Cholesteryl Glucoside, GluChol, Glucosyl Cholesterol

    A glycosylated derivative of cholesterol
  5. GC43244 Chlorin e6

    二氢卟吩E6,Ce6

    Chlorin e6(Ce6) 是第二代光敏剂。
  6. GC43242 Chloramphenicol Succinate

    琥珀酸氯霉素

    A prodrug form of chloramphenicol
  7. GC43240 Chloramphenicol Acetate

    氯霉素醋酸

    An acetylated version of chloramphenicol
  8. GC43239 Chk2 Inhibitor

    SC-203885

    A Chk2 inhibitor
  9. GC43237 Chevalone C A fungal metabolite
  10. GC43225 Celecoxib Carboxylic Acid Acyl-β-D-Glucuronide

    塞来昔布羧酸酰基-Β-D-葡糖苷酸

    A metabolite of celecoxib
  11. GC43222 Cefazolin-13C2,15N

    头孢唑啉-13C2-15N

    An internal standard for the quantification of cefazolin
  12. GC43216 CCR4 Antagonist (hydrochloride)

    C-021

    A CCR4 antagonist
  13. GC43212 CCG-232601 An inhibitor of the Rho/MRTF/SRF transcriptional pathway
  14. GC43205 CAY10731 A fluorescent H2S probe
  15. GC43197 CAY10711 A substituted diamine antibiotic
  16. GC43196 CAY10704 An inhibitor of HCV infection
  17. GC43190 CAY10682 A dual inhibitor of p53-Mdm2 interaction and NF-κB signaling
  18. GC43189 CAY10681 A dual modulator of p53-MDM2 interaction and NF-κB signaling
  19. GC43186 CAY10648 Intermediate in the synthesis of CRTH2/DP2 antagonists
  20. GC43181 CAY10597 A potent CRTH2/DP2 receptor antagonist
  21. GC43176 CAY10575

    IKK2 Inhibitor 3, Polo-like Kinase Inhibitor 1

    An IKKβ and Plk1 inhibitor
  22. GC43165 CAY10512 A potent inhibitor of NF-κB
  23. GC43161 CAY10502 A potent inhibitor of cPLA2α
  24. GC43149 CAY10404 A COX-2 inhibitor
  25. GC43146 Caspase-9 Inhibitor III (trifluoroacetate salt)

    Ac-LEHD-CMK

    A caspase-9 inhibitor
  26. GC43144 Carfilzomib Impurity 13 (hydrochloride) A potential impurity found in commercial carfilzomib preparations
  27. GC43143 Cardanol triene A tyrosinase inhibitor
  28. GC43142 Cardanol diene A tyrosinase inhibitor
  29. GC43139 Capsanthin

    辣椒红

    A carotenoid with diverse biological activities
  30. GC43138 CAP 3 A cholic acid-peptide conjugate with antibacterial activity
  31. GC43136 Campestanol

    油菜甾醇

    A phytosterol

  32. GC43135 Cambendazol

    坎苯达唑

    An anthelmintic agent
  33. GC43131 Calpinactam

    FKI-4905

    A fungal metabolite
  34. GC43129 CALP1 (trifluoroacetate salt)

    Calcium-like Peptide 1

    CALP1 (trifluoroacetate salt)是一种由八个残基组成的互补肽,可结合钙调蛋白的钙结合位点(EF手结构域)。
  35. GC43113 Caerulein (acetate)

    Ceruletide

    An oligopeptide
  36. GC43110 C8 Galactosylceramide (d18:1/8:0)

    Galactosylceramide (d18:1/8:0), N-octanoyl-βD-Galactosylceramide, GalCer(d18:1/8:0)

    A synthetic bioactive sphingolipid
  37. GC43105 C8 Ceramide (d18:1.8:0)

    N-辛酰基-D-神经鞘氨醇; N-Octanoyl-D-erythro-sphingosine

    A cell-permeable ceramide analog
  38. GC43084 C4 Ceramide (d18:1/4:0)

    C4酰胺,Cer(d18:1/4:0)

    A bioactive sphingolipid
  39. GC43077 C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z))

    (3’-sulfo)Galβ-Cer(d18:1/24:1), N-Nervonoyl Sulfatide, C24:1 Sulfatide, cis-Tetracosenoyl Sulfatide, N-Tetracosenoyl (cis-15) Sulfatide

    A sulfatide
  40. GC43076 C24 Phytosphingosine (t18:0/24:0)

    N-二十四酰植物鞘胺醇

    A sphingolipid
  41. GC43071 C22 Sphingomyelin (d18:1/22:0)

    SM(d18:1/22:0), Sphingomyelin (d18:1/22:0), N-docosanoyl-D-erythro-Sphingosylphosphorylcholine

    A sphingolipid
  42. GC43060 C2 Adamantanyl Globotriaosylceramide (d18:1/2:0) C2 Adamantanyl globotriaosylceramide (AdaGb3) is a bioactive sphingolipid and water-soluble form of globotriaosylceramide that contains an adamantanyl group in place of the fatty acyl chain.
  43. GC43052 C18 Phytoceramide (t18:0/18:0)

    N-硬脂酰植物鞘胺醇

    A bioactive sphingolipid
  44. GC43049 C18 Globotriaosylceramide (d18:1/18:0)

    C18 Ceramide Trihexoside (d18:1/18:0), Gb3(d18:1/18:0), N-Octadecanoyl-ceramide trihexoside

    A sphingolipid
  45. GC43032 C16 Globotriaosylceramide (d18:1/16:0)

    C16 Ceramide Trihexoside (d18:1/16:0), Gb3 (d18:1/16:0), N-Hexadecanoyl-ceramide trihexoside

    A sphingolipid
  46. GC43031 C16 Galactosylceramide (d18:1/16:0)

    Galactosylceramide (d18:1/16:0), Galβ-Cer(d18:1/16:0), GalCer(d18:1/16:0), N-Hexadecanoyl-β-D-Galactosylceramide, Palmitoyl GalCer

    A sphingolipid
  47. GC43007 C12 Galactosylceramide (d18:1/12:0)

    N-Dodecanoyl-β-D-Galactosylceramide, Galactosylceramide (d18:1/12:0), GalCer(d18:1/12:0)

    A bioactive sphingolipid
  48. GC42978 Bromamphenicol A dibrominated derivative of chloramphenicol
  49. GC42969 bpV(phen) (potassium hydrate)

    Bisperoxovanadium(phen), Potassium Bisperoxo(1,10phenanthroline) oxovanadate (V)

    An inhibitor of phosphatases
  50. GC42967 Boromycin

    NSC 121380

    A boron-containing macrolide antibiotic
  51. GC42957 BMS-8 An inhibitor of the PD-1/PD-L1 interaction

Items 3051 to 3100 of 4243 total

per page

Set Descending Direction